Insider activities archive   |   Recent insider buys   |   Top 10 insider buys   |   Search Insiders!



Insider Trading: RENOVIS INC

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of RENOVIS INC in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of RENOVIS INC since year 2005. Table 2 shows the detailed insider transactions of RENOVIS INC since 2005. The reporting company's ticker symbol is RNVS. The reporting company's CIK number is 1118361.

The total value of stock buying since 2005 is $2,106,554. The total value of stock sales is $31,827,761. The total value of stock exercises is $214,846.


1 year stock price chart,   1 day stock price chart
opopp
opopopop

Figure 1. Monthly insider transaction values at RENOVIS INC (RNVS) in the past 24 months. The trade values of insider stock buys, sales, and option exercises are in logarithmic scale as shown on the right axis labels. The detailed monthly and daily insider transactions are listed in the 2 tables below.

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2007

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2008

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • $1,801k

    $180k

    $18k

    $1k

  • Buy
  • Sale
  • Option Exercise

Figure 2. Average prices of insider buys, sales, and option exercises at RENOVIS INC (RNVS) in the past 24 months. See table 2 for insider transaction details.

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2007

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2008

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • $14.70

    $11.02

    $7.35

    $3.67



Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for RENOVIS INC (RNVS).
Trading Period
year-month  
Insider Buying     
Shares               Value ($)
Insider Sales     
Shares               Value ($)
Option Exercises     
Shares               Value ($)
2008-04 20,000 45,598 800,000 1,788,000 0 0
2008-03 113,446 259,844 0 0 0 0
2008-02 750,998 1,801,112 0 0 0 0
2006-12 0 0 40,000 123,204 0 0
2006-11 0 0 51,852 168,037 0 0
2006-10 0 0 51,649 247,532 0 0
2006-09 0 0 6,000 88,176 0 0
2006-08 0 0 6,000 73,710 0 0
2006-07 0 0 6,000 92,122 0 0
2006-06 0 0 6,000 97,638 0 0
2006-05 0 0 8,650 149,256 58,911 72,902
2006-04 0 0 24,150 493,687 79,353 84,874
2006-03 0 0 702,150 15,107,402 21,000 36,410
2006-02 0 0 33,500 706,885 10,000 11,250
2006-01 0 0 27,150 491,815 1,000 9,410
2005-12 0 0 7,650 121,301 0 0
2005-11 0 0 16,650 234,240 0 0
2005-10 0 0 8,650 116,252 0 0
2005-09 0 0 8,650 114,486 0 0
2005-08 0 0 9,650 143,231 0 0
2005-07 0 0 20,650 312,057 0 0
2005-06 0 0 17,050 234,307 0 0
2005-05 0 0 685,554 10,924,423 0 0

Table 2. Detailed insider stock purchases, sales, and option exercises for RENOVIS INC (RNVS)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2008-04-22 Mm Asset Management Inc. (10% Owner) Purchase 10,000 2.28 22,799
2008-04-22 Mm Asset Management Inc. (10% Owner) Sale 400,000 2.24 894,000
2008-04-22 Mmcap International Inc. Spc (10% Owner) Purchase 10,000 2.28 22,799
2008-04-22 Mmcap International Inc. Spc (10% Owner) Sale 400,000 2.24 894,000
2008-03-07 Mm Asset Management Inc. (10% Owner) Purchase 28,400 2.28 64,610
2008-03-07 Mmcap International Inc. Spc (10% Owner) Purchase 28,400 2.28 64,610
2008-03-03 Mm Asset Management Inc. (10% Owner) Purchase 28,323 2.31 65,312
2008-03-03 Mmcap International Inc. Spc (10% Owner) Purchase 28,323 2.31 65,312
2008-02-21 Mm Asset Management Inc. (10% Owner) Purchase 14,834 2.44 36,194
2008-02-21 Mmcap International Inc. Spc (10% Owner) Purchase 14,834 2.44 36,194
2008-02-20 Mm Asset Management Inc. (10% Owner) Purchase 79,701 2.46 196,462
2008-02-20 Mmcap International Inc. Spc (10% Owner) Purchase 79,701 2.46 196,462
2008-02-13 Mm Asset Management Inc. (10% Owner) Purchase 12,402 2.56 31,687
2008-02-13 Mmcap International Inc. Spc (10% Owner) Purchase 12,402 2.56 31,687
2008-02-12 Mm Asset Management Inc. (10% Owner) Purchase 165,000 2.39 393,878
2008-02-12 Mmcap International Inc. Spc (10% Owner) Purchase 165,000 2.39 393,878
2008-02-11 Mm Asset Management Inc. (10% Owner) Purchase 103,562 2.34 242,335
2008-02-11 Mmcap International Inc. Spc (10% Owner) Purchase 103,562 2.34 242,335
2006-12-15 Walker John Peter (Director) Sale 40,000 3.08 123,204
2006-11-20 Goodman Corey S (President and CEO) Sale 1,852 3.38 6,262
2006-11-02 Doyle John C (SVP, Finance/Operations & CFO) Sale 50,000 3.24 161,775
2006-10-27 Goodman Corey S (President and CEO) Sale 20,649 3.52 72,676
2006-10-26 Goodman Corey S (President and CEO) Sale 25,000 3.74 93,530
2006-10-02 Goodman Corey S (President and CEO) Sale 6,000 13.55 81,326
2006-09-01 Goodman Corey S (President and CEO) Sale 6,000 14.70 88,176
2006-08-01 Goodman Corey S (President and CEO) Sale 6,000 12.28 73,710
2006-07-03 Goodman Corey S (President and CEO) Sale 6,000 15.35 92,122
2006-06-01 Goodman Corey S (President and CEO) Sale 6,000 16.27 97,638
2006-05-25 Doyle John C (VP, Finance & CFO) Option Exercise 10,300 1.24 12,746
2006-05-16 Kelly Michael Gerald (SVP, Research & Development) Sale 1,000 15.70 15,700
2006-05-03 Pathak Dushyant (VP, Corporate Development) Option Exercise 48,611 1.24 60,156
2006-05-02 Serafini Tito (VP, Technology) Sale 1,650 17.06 28,148
2006-05-01 Goodman Corey S (President and CEO) Sale 6,000 17.57 105,408
2006-04-17 Kelly Michael Gerald (SVP, Research & Development) Sale 1,000 18.65 18,650
2006-04-12 Doyle John C (VP, Finance & CFO) Option Exercise 30,000 1.24 37,125
2006-04-12 Goodman Corey S (President and CEO) Option Exercise 49,353 .97 47,749
2006-04-06 Goodman Corey S (President and CEO) Sale 12,500 20.29 253,631
2006-04-03 Goodman Corey S (President and CEO) Sale 9,000 20.81 187,251
2006-04-03 Serafini Tito (VP, Technology) Sale 1,650 20.70 34,155
2006-03-20 Pathak Dushyant (VP, Corporate Development) Sale 2,000 24.00 48,000
2006-03-16 Kelly Michael Gerald (SVP, Research & Development) Sale 4,000 23.38 93,520
2006-03-16 Doyle John C (VP, Finance & CFO) Sale 20,000 23.37 467,440
2006-03-16 Doyle John C (VP, Finance & CFO) Option Exercise 20,000 1.35 27,000
2006-03-15 Perry Marlene F (Vice President, Human Resource) Sale 1,000 22.72 22,720
2006-03-15 Perry Marlene F (Vice President, Human Resource) Option Exercise 1,000 9.41 9,410
2006-03-06 Goodman Corey S (President and CEO) Sale 25,000 21.94 548,624
2006-03-02 Serafini Tito (VP, Technology) Sale 3,650 22.00 80,300
2006-03-02 Penhoet Edward (Director) Sale 625,000 21.40 13,375,000
2006-03-01 Goodman Corey S (President and CEO) Sale 9,000 21.94 197,486
2006-02-27 Walker John Peter (Director) Sale 20,000 21.72 434,350
2006-02-16 Kelly Michael Gerald (SVP, Research & Development) Sale 1,000 20.36 20,360
2006-02-08 Doyle John C (VP, Finance & CFO) Option Exercise 10,000 1.12 11,250
2006-02-06 Goodman Corey S (President and CEO) Sale 12,500 20.17 252,175
2006-01-26 Perry Marlene F (Vice President, Huma) Sale 1,000 20.00 20,000
2006-01-26 Perry Marlene F (Vice President, Huma) Option Exercise 1,000 9.41 9,410
2006-01-26 Goodman Corey S (President and CEO) Sale 2,439 20.00 48,780
2006-01-25 Goodman Corey S (President and CEO) Sale 561 20.00 11,220
2006-01-25 Serafini Tito (VP, Chief Discovery) Sale 2,000 20.00 40,000
2006-01-18 Goodman Corey S (President and CEO) Sale 12,500 19.00 237,500
2006-01-17 Kelly Michael Gerald (VP, Drug Discovery) Sale 1,000 18.18 18,180
2006-01-03 Goodman Corey S (President and CEO) Sale 6,000 15.18 91,110
2006-01-03 Serafini Tito (VP, Chief Discovery) Sale 1,650 15.17 25,025
2005-12-02 Serafini Tito (VP, Chief Discovery) Sale 1,650 15.88 26,195
2005-12-01 Goodman Corey S (President and CEO) Sale 6,000 15.85 95,106
2005-11-17 Kelly Michael Gerald (VP, Drug Discovery) Sale 6,000 13.96 83,790
2005-11-15 Kelly Michael Gerald (VP, Drug Discovery) Sale 3,000 15.00 45,000
2005-11-02 Serafini Tito (VP, Chief Discovery) Sale 1,650 13.64 22,506
2005-11-01 Goodman Corey S (President and CEO) Sale 6,000 13.82 82,944
2005-10-21 Pathak Dushyant (VP, Corporate Develo) Sale 1,000 12.92 12,920
2005-10-03 Goodman Corey S (President and CEO) Sale 6,000 13.51 81,048
2005-10-03 Serafini Tito (VP, Chief Discovery) Sale 1,650 13.51 22,284
2005-09-21 Pathak Dushyant (VP, Corporate Develo) Sale 1,000 13.10 13,100
2005-09-02 Serafini Tito (VP, Chief Discovery) Sale 1,650 13.26 21,880
2005-09-01 Goodman Corey S (President and CEO) Sale 6,000 13.25 79,506
2005-08-22 Pathak Dushyant (VP, Corporate Develo) Sale 1,000 13.43 13,430
2005-08-10 Moreadith Randall (Chief Medical Office) Sale 1,000 13.30 13,300
2005-08-02 Serafini Tito (VP, Chief Discovery) Sale 1,650 15.24 25,139
2005-08-01 Goodman Corey S (President and CEO) Sale 6,000 15.23 91,362
2005-07-21 Pathak Dushyant (VP, Corporate Develo) Sale 1,000 16.20 16,200
2005-07-05 Serafini Tito (VP, Chief Discovery) Sale 1,650 15.06 24,849
2005-07-01 Goodman Corey S (President and CEO) Sale 12,000 15.06 180,672
2005-06-24 Kelly Michael Gerald (VP, Drug Discovery) Sale 3,000 15.00 45,000
2005-06-21 Pathak Dushyant (VP, Corporate Develo) Sale 1,000 14.69 14,690
2005-06-15 Moreadith Randall (Chief Medical Office) Sale 5,400 13.34 72,063
2005-06-02 Serafini Tito (VP, Chief Discovery) Sale 1,650 12.96 21,392
2005-06-01 Goodman Corey S (President and CEO) Sale 6,000 13.53 81,162
2005-05-23 Pathak Dushyant (VP, Corporate Develo) Sale 1,000 17.25 17,250
2005-05-12 Walker John Peter (Director) Sale 10,000 18.00 180,000
2005-05-10 Crowell Nancy M (Director) Sale 249,000 16.96 4,099,386
2005-05-09 Crowell Nancy M (Director) Sale 150,000 15.65 2,347,949
2005-05-06 Scolnick Edward M (Director) Sale 80,000 14.50 1,159,600
2005-05-04 Pathak Dushyant (VP, Corporate Develo) Sale 1,000 13.50 13,500
2005-05-04 Goodman Corey S (President and CEO) Sale 6,000 14.73 88,380

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of RENOVIS INC (symbol RNVS, CIK number 1118361) see the Securities and Exchange Commission (SEC) website.

© 2005-2008, insider-monitor.com. All rights reserved.